Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Group A – Children treated with radiation:
- Children and teenagers aged 0–17 years old
- Children who have been diagnosed with a primary brain tumour through surgery, biopsy, or another diagnostic method, at Uppsala University Hospital or another university hospital in Sweden
- Children who have been referred for radiation treatment at the Skandion Clinic in Uppsala and/or their local hospital, with or without other cancer treatments
Group B – Children not treated with radiation:
- Children and teenagers aged 0–17 years old
- Children who have been diagnosed with a primary brain tumour through surgery, biopsy, or another diagnostic method, at Uppsala University Hospital or another university hospital in Sweden
- Children who have not been referred for radiation treatment, and who are receiving other cancer treatments or no additional treatment
Group C – Healthy comparison group:
- Children and teenagers aged 0–17 years old at the time of joining the trial
Who may not be able to join:
Groups A and B:
- Children whose tumour is located only in the spinal cord, with no brain involvement
- Children whose tumour was considered unable to be cured from the time of diagnosis (for example, a type of tumour called diffuse intrinsic pontine glioma)
Group C (healthy comparison group):
- Children who have a long-term health condition that requires ongoing daily medication
All groups:
- Children or families where language barriers make it not possible to give informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Arja Harila, MD, PhD, Uppsala University
Phone: 0046-(0)18-611-0114
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Biomarker(s) of brain injury
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.